微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 35.47% | -13.06% | -7.75% | 102/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 38.45% | -3.27% | 4.48% | 93/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 36.8% | -17.4% | -7.15% | 95/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 39.64% | -13.06% | -2.85% | 91/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 40.8% | -11.67% | 2.64% | 89/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 39.75% | -5.94% | -10.77% | 91/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 44.55% | 0.95% | -2.28% | 86/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 45.59% | 1.58% | -1.29% | 83/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 46.19% | 3.87% | 9.29% | 84/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 42.26% | 7.17% | -4.23% | 85/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 44.13% | 15.67% | -1.68% | 87/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 44.88% | 17.81% | 0.93% | 85/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 44.47% | 19.01% | 12.76% | 87/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 39.44% | 2.92% | 3.37% | 91/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 38.15% | -5.74% | 0.14% | 103/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 38.1% | -6.9% | 1.96% | 96/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 37.37% | -11.93% | -2.48% | 100/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 38.32% | -12.66% | -5.33% | 90/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 40.48% | 9.84% | -1.09% | 105/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 40.92% | 6.57% | -3.55% | 89/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 42.43% | 20.27% | -3.3% | 96/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 43.87% | 29.7% | 19.06% | 78/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 36.85% | 7.16% | -4.03% | 111/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 38.4% | 7.97% | 8.85% | 76/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 35.28% | 2.89% | 4.29% | 100/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 33.83% | -16.29% | -1.64% | 70/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 34.39% | -1.57% | -3.3% | 100/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 35.56% | 5.5% | 3.73% | 53/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 34.28% | -2.54% | -15.15% | 62/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 40.41% | -1.68% | 15.65% | 39/141 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 34.94% | -8.05% | 3.65% | 91/141 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 33.71% | -11.75% | -4.18% | 42/141 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 35.18% | -11.53% | -14.39% | 44/141 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 41.09% | -25.08% | 8.15% | 35/141 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 38% | -29.73% | -0.52% | 80/141 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 38.2% | -36.36% | -3.94% | 33/141 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 39.76% | -36.6% | -27.5% | 42/141 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 54.85% | -10.82% | 1.43% | 21/141 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 54.08% | -7.91% | -9.91% | 46/141 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 60.02% | -5.35% | -4.29% | 15/141 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 62.71% | 1.78% | 1.97% | 17/141 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 61.5% | -5.35% | 4.74% | 9/141 | 50.24% | 健帆生物 | 83.86% | 行业排名> |